ULTRAGENYX PHARMACEUTICAL INC. - COMMON STOCK

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

19 4 2023 16:01:00 提供 Nasdaq GlobeNewswire

Ultragenyx to Present at Guggenheim’s Genomic Medicines and Rare Disease Days

28 3 2023 16:01:00 提供 Nasdaq GlobeNewswire

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

21 3 2023 08:30:00 提供 Nasdaq GlobeNewswire

Ultragenyx Appoints Dr. Eric Crombez Chief Medical Officer and Executive Vice President

14 3 2023 08:30:00 提供 Nasdaq GlobeNewswire

Ultragenyx to Participate in Orphan Neuro Panel at Cowen Healthcare Conference

28 2 2023 16:01:00 提供 Nasdaq GlobeNewswire

Ultragenyx Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Update

16 2 2023 16:01:00 提供 Nasdaq GlobeNewswire

Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2022 Financial Results and Corporate Update

09 2 2023 16:01:00 提供 Nasdaq GlobeNewswire

Ultragenyx Reports Preliminary 2022 Revenue; Guidance for 2023 Revenue and Cash Usage; Pipeline Updates and 2023 Milestones

06 1 2023 16:01:00 提供 Nasdaq GlobeNewswire

Ultragenyx to Present at the 41st Annual J.P. Morgan Healthcare Conference

04 1 2023 06:00:00 提供 Nasdaq GlobeNewswire

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

21 12 2022 16:01:00 提供 Nasdaq GlobeNewswire

Ultragenyx to Present at Piper Sandler Healthcare Conference

22 11 2022 16:01:00 提供 Nasdaq GlobeNewswire

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

18 11 2022 16:05:00 提供 Nasdaq GlobeNewswire

Ultragenyx Announces Departure of Chief Financial Officer

10 11 2022 16:15:00 提供 Nasdaq GlobeNewswire

Ultragenyx to Present at Upcoming Healthcare Conferences

09 11 2022 16:01:00 提供 Nasdaq GlobeNewswire

Ultragenyx Reports Third Quarter 2022 Financial Results and Corporate Update

02 11 2022 16:05:01 提供 Nasdaq GlobeNewswire

Ultragenyx to Host Conference Call for Third Quarter 2022 Financial Results and Corporate Update

27 10 2022 16:01:00 提供 Nasdaq GlobeNewswire

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

04 10 2022 16:30:00 提供 Nasdaq GlobeNewswire

Ultragenyx and Mereo BioPharma to Present Setrusumab Data Update at ASBMR

09 9 2022 20:22:15 提供 Nasdaq GlobeNewswire

Ultragenyx to Participate at Citi BioPharma Conference

01 9 2022 16:01:00 提供 Nasdaq GlobeNewswire

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

17 8 2022 16:01:00 提供 Nasdaq GlobeNewswire